Immunological and metabolic optimization of tumor neoantigen vaccines
Tumor initiation and progression are highly intricate biological processes, and mutation-driven tumorigenesis is a primary underlying cause. Personalized cancer vaccines have been developed to exploit these specific mutations, particularly in the form of tumor neoantigens, to induce immune responses
Authors
- Xiafeng Wang
- Zhangping Huang
- Shufeng Xu (ORCID: https://orcid.org/0000-0001-9098-7504)
- Jianfeng Huang (ORCID: https://orcid.org/0000-0003-0107-3482)
- Ji Wang (ORCID: https://orcid.org/0000-0002-8631-3264)
- Peng Lin (ORCID: https://orcid.org/0000-0002-1192-3543)
Institutions
- Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Cancer Biology and Medicine
- Published
- 2025-09-30
- DOI
- https://doi.org/10.20892/j.issn.2095-3941.2025.0445
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Sun Yat-sen University